- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06280404
Body First Approach in Lap Cholecystectomy in Cases With Obscure Calot's Triangle
February 26, 2024 updated by: Abdelrahman Abdullah Badawy, Assiut University
Body First Approach in Laparoscopic Cholecystectomy in Cases With Obscure Calot's Triangle
The aim of this study is to evaluate the body first approach on the rate of conversion to open technique & VBI in patients with obscure calot's triangle.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Gallbladder disease is one of the most common reasons patients are referred to a general surgeon.
Laparoscopic cholecystectomy (LC) is the current standard of care for symptomatic cholelithiasis.
Despite being considered a low-risk surgery, bile duct injuries (BDIs) have occurred at a constant rate in the last 30 years, leaving devastating consequences on the affected patients.
However vasculobiliary injury (VBI) is a rare but critical complication of (LC).
So we need to follow critical view of safety.
The critical view of safety (CVS) described by Strasberg is considered as the one of the most important critical factors for overall safety during LC.
The CVS consists of three essential component or steps: 1) dissection of the hepatocystic triangle (HCT); 2) exposure of at least lower one third of the cystic plate (CP); and 3) demonstration of only two tubular structures (cystic duct and cystic artery) that remain attached to the gallbladder (after components 1 and 2 are achieved).
All these three steps must be completed before considering that CVS has been achieved.
However in some cases Calot's triangle can't be demonstrated due to dense adhesions.
Conversion with retrograde approach (fundus first) was an option for these cases.
However a retrograde approach can be achieved laparoscopically by starting dissection by body to use the fundus attachment for retraction which is called (the "body-first approach") that may decrease the possibility of VBI.
Recent studies deficient in evaluation of outcome of (body first approach).
So the interest of our study is to evaluate the outcome of body first approach in difficult cases and cases with obscure Calot's triangle in (LC) and to evaluate its feasibility and safety in (LC).
Study Type
Observational
Enrollment (Estimated)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Abdelrahman Abdullah Badawy, Resident
- Phone Number: 01010016178
- Email: abdobadawy28.ab@gmail.com
Study Contact Backup
- Name: Samir Ahmed Ammar, Professor
- Phone Number: 01141459567
- Email: Samirahmed22@aun.edu.eg
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
All adult patients aging above 18 years old fit for (LC), who presented with symptomatic gall stones by clinical examination and detected by preoperative imaging and intra-operatively have obscure Calot's triangle.
Description
Inclusion Criteria:
- All adult patients aging above 18 years old fit for (LC), who presented with symptomatic gall stones by clinical examination and detected by preoperative imaging and intra-operatively have obscure Calot's triangle.
Exclusion Criteria:
- unfit patients.
- Patients with calcular obstructive jaundice.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Safe laparoscopic cholecystectomy.
Time Frame: Baseline
|
To achieve critical view of safety during lap cholecystectomy
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of the body first approach technique
Time Frame: Baseline
|
evaluate the body first approach on the rate of conversion to open technique & VBI in patients with obscure calot's triangle.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
- Laparoscopic cholecystectomy: semi-top-down technique
- Postoperative analgesic effect of ultrasound-guided rectus sheath block and local anesthetic infiltration after laparoscopic cholecystectomy: Results of a prospective randomized controlled trial
- Application of a novel surgical difficulty grading system during laparoscopic cholecystectomy
- Randomized controlled trial comparing the effects of usual gas release, active aspiration, and passive-valve release on abdominal distension in patients who have undergone laparoscopic cholecystectomy
- Body-first approach of laparoscopic cholecystectomy for minimizing vasculobiliary injury: Initial experience
- Laparoscopic Cholecystectomy
- A three-step conceptual roadmap for avoiding bile duct injury in laparoscopic cholecystectomy: an invited perspective review
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
March 15, 2024
Primary Completion (Estimated)
March 15, 2025
Study Completion (Estimated)
August 8, 2025
Study Registration Dates
First Submitted
February 20, 2024
First Submitted That Met QC Criteria
February 26, 2024
First Posted (Estimated)
February 28, 2024
Study Record Updates
Last Update Posted (Estimated)
February 28, 2024
Last Update Submitted That Met QC Criteria
February 26, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Body first in lap chole
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cholecystitis, Chronic
-
The University of Texas Health Science Center at...CompletedAcute Cholecystitis | Chronic CholecystitisUnited States
-
Ain Shams UniversityCompletedCholecystitis | Chronic Calculous Cholecystitis | Acute Calculous CholecystitisEgypt
-
Lumbini Medical CollegeCompletedCholedocholithiasis With Cholecystitis With Obstruction | Choledocholithiasis With Acute and Chronic Cholecystitis | Cholelithiasis With Acute and Chronic Cholecystitis
-
The University of Texas Health Science Center at...CompletedCholecystitis, Acute | Cholecystitis, ChronicUnited States
-
Medipol UniversityCompletedCholecystitis, Acute | Cholecystitis | Cholecystitis, ChronicTurkey
-
Suez UniversitySouth Valley UniversityEnrolling by invitationChronic Calculous CholecystitisEgypt
-
Samsun Education and Research HospitalCompletedAcute Cholecystitis With Chronic CholecystitisTurkey
-
Medipol UniversityCompletedCholecystitis, Acute | Cholecystitis | Cholecystitis, ChronicTurkey
-
Kazakhstan Scientific Society for Study of intestine...Not yet recruitingChronic CholecystitisKazakhstan
-
Ewha Womans University Mokdong HospitalUnknownCholecystitis, Acute | Cholecystitis, ChronicKorea, Republic of
Clinical Trials on Lap cholecystectomy
-
Zagazig UniversityCompleted
-
Zagazig UniversityCompleted
-
Zhongnan HospitalNot yet recruiting
-
NYU Langone HealthHope FoundationCompleted
-
Baskent UniversityMersin UniversityCompletedPain, Acute | Nurse's Role | Infant DevelopmentTurkey
-
Hospital Son LlatzerCompleted
-
Jeffrey L Zitsman, MDCompletedObstructive Sleep Apnea Syndrome | Metabolic Syndrome | Insulin Resistance | Morbid Obesity | Nonalcoholic Fatty Liver DiseaseUnited States
-
The First Affiliated Hospital of Guangzhou Medical...Unknown
-
Vectorious Medical Technologies Ltd.RecruitingHeart FailureUnited States
-
Apollo Endosurgery, Inc.CompletedObesityUnited Kingdom, Australia, United States, Italy, Canada, Belgium